Company news
Equasens Sa (EURONEXT:EQS) news
Every Equasens Sa press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Strong H1 2026 business performance: H1 revenue of €124.5 million (+7.3% on a reported basis) and ARR of €111.1 million at 30 June 2026 (...
July 30, 2026
Solide performance commerciale au S1 2026 : Chiffre d’affaires semestriel de 124,5 M€ (+7,3% en publié) et ARR de 111,1 M€ au 30 juin 202...
July 29, 2026
BILAN SEMESTRIEL S1 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC NATIXIS ODDO BHF
July 27, 2026
Equasens : RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 25 JUNE 2026
July 2, 2026
RESULTAT DU VOTE DES RESOLUTIONS PRESENTEES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE
July 1, 2026
Equasens renews its governance with the appointment of Dominique Pautrat as Chairman of the Board and four new directors
June 25, 2026
ANNUAL ORDINARY GENERAL MEETING: MEETING NOTICE - ONLINE AVAILABILITY OF MEETING MATERIALS - WEBCAST LIVE
June 10, 2026
Solid Q1 2026 performance: revenue of €61.4 million (+7.7% reported)
April 29, 2026
2025 annual results: Equasens reports a solid performance across all financial indicators
March 30, 2026
Strong commercial performance in 2025: Annual Recurring Revenue (ARR) of €108.0m (+8.8% as reported on 31 December 2025) and full-year re...
February 5, 2026
EQUASENS ACCELERATES ITS DIGITAL TRAINING STRATEGY FOR HEALTHCARE PROFESSIONALS WITH THE ACQUISITION OF EREVO, A LEADING PURE-PLAY E-LEAR...
January 5, 2026
EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR
December 10, 2025
Equasens: Q3 2025 revenue
November 5, 2025
Equasens: 2025 half-year results
September 26, 2025
Equasens: H1 revenue at 30 June 2025: €116.0m
July 31, 2025
Equasens: Appointment at the head of the Pharmagest Division
July 3, 2025
Equasens: General meeting - Results of the votes
July 1, 2025
Equasens: acquisition of DIS and RESURGENCES BUSINESSES
June 30, 2025
Equasens: availability of AGM preparatory materials
June 6, 2025
Equasens: Q1 revenue at 31 March 2025
May 12, 2025
Equasens: EXCLUSIVE NEGOTIATIONS INITIATED WITH A FRENCH SOFTWARE EDITOR
April 30, 2025
Equasens: 2024 annual results
March 28, 2025
Equasens: 2024 annual revenue
February 6, 2025
Equasens: strategic acquisition of Calimed, a SaaS software expert for private practitioners and surgeons
December 27, 2024
Equasens: 2024 nine-month revenue: €158.2 million - Return to growth in Q3 (+0.3%)
November 7, 2024
Equasens: 2024 half-year results
September 27, 2024
Equasens: H1 2024 revenue
August 2, 2024
Equasens: RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 27 JUNE 2024
July 5, 2024
Equasens: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS
June 10, 2024